Weight loss news and articles

Friday 10 October, 2008
coming soon...
Khichadi Recipe
Calorie Intake & BMI calculator
Convert pounds to kilograms

Health related products & services:

Latest weight loss news and articles

See also : Alternative medicine news | Alzheimers news | back pain news | Cancer news | Latest depression News | Diabetes news | Diet news | Exercise and fitness news | Healthy eating news | Vitamin news


10/10/2008 12:00 PM
  • Washington Post Examines National Weight-Loss Effort Targeting Black Community
  • The Washington Post on Saturday examined the 50 Million Pound Challenge, which seeks to reduce obesity and encourage healthy lifestyles in the black community.
    10/10/2008 04:00 AM
  • More Action Needed On Preventative Health - Australian Medical Association
  • AMA President Dr Rosanna Capolingua said the Preventative Health Taskforce discussion paper launched today was a welcome contribution, worthy of broad community attention. "Doctors have long spoken out about the threats obesity, alcohol and tobacco pose to our community. It is encouraging and appropriate that the focus on these crucial areas is increasing," she said. "Every GP in the country understands the issues.
    10/09/2008 05:00 AM
  • Guidelines Urge Physical Activity During Pregnancy
  • Moderate physical activity during pregnancy does not contribute to low birth weight, premature birth or miscarriage and may actually reduce the risk of complications, according to a Michigan State University professor who contributed to the U.S. government's first-ever guidelines on physical activity.
    10/09/2008 05:00 AM
  • Kids' Weighty Issues Tackled At Obesity And Eating Disorder Conference
  • Health professionals from across Australia will meet in Brisbane at a University of Queensland conference focused on prevention and treatment of childhood obesity and eating disorders. The two-day conference, Perspectives on Childhood Obesity and Eating Disorders: from Prevention to Treatment, is hosted by UQ's Children's Nutrition Research Centre.
    10/09/2008 04:00 AM
  • Preventing Childhood Obesity - Training Course Brings International Researchers To Queensland University Of Technology, Australia
  • International researchers and academics with an interest in preventing childhood obesity will visit QUT later this month for a training course which will showcase some key technologies in measuring body composition, energy expenditure and physical activity. Professor Andrew Hills and his Energy Metabolism Group will host a week-long training course with around 20 attendees from a number of countries in the Asia-Pacific region.
    10/08/2008 09:00 AM
  • Understanding Eating Habits In Children Could Help Stave Off Unhealthy Relationships With Food
  • At dinner time, parents will often tell their child to clean their plate. However, that old maxim might lead kids to eat more than they need, especially when portions are adult-sized or supersized. In findings presented at The Obesity Society's Annual Meeting on Oct. 7, children took more food when larger portions were made available to them. Jennifer Fisher, Ph.D.
    10/08/2008 09:00 AM
  • How Fatty Foods Curb Hunger
  • Fatty foods may not be the healthiest diet choice, but those rich in unsaturated fats - such as avocados, nuts and olive oil - have been found to play a pivotal role in sending this important message to your brain: stop eating, you're full. A new study by UC Irvine pharmacologists shows that these fats trigger production of a compound in the small intestine that curbs hunger pangs.
    10/08/2008 09:00 AM
  • HHS Announces Physical Activity Guidelines For Americans, USA
  • Adults gain substantial health benefits from two and a half hours a week of moderate aerobic physical activity, and children benefit from an hour or more of physical activity a day, according to the new Physical Activity Guidelines for Americans. The comprehensive set of recommendations for people of all ages and physical conditions was released today by the U.S. Department of Health and Human Services.
    10/08/2008 05:00 AM
  • Fighting Diabetes by Killing 'Angry' Immune Cells In Fat
  • By killing off "angry" immune cells that take up residence in obese fat and muscle tissue, researchers have shown that they can rapidly reverse insulin resistance in obese mice. The findings reported in the October Cell Metabolism, a publication of Cell Press, suggest that treatments aimed at specific subsets of the so-called macrophage cells might offer a very effective new antidiabetic therapy, according to the researchers.
    10/08/2008 05:00 AM
  • Ingredient In Olive Oil Wards Off Hunger Pangs
  • A fatty acid found in abundance in olive oil and other "healthy" unsaturated fats has yet another benefit: it helps keep the body satisfied to prolong the time between meals. A new study in the October Cell Metabolism, a publication of Cell Press, reveals that once this type of fat, known as oleic acid, reaches the intestine, it is converted into a lipid hormone (oleoylethanolamide, or OEA) that wards off the next round of hunger pangs.
    10/08/2008 03:00 AM
  • Online Game 'Color My Pyramid' Battles Obesity In DC Schools
  • An online game might be the secret weapon for winning the war against childhood obesity. Researchers at George Mason University have designed and tested a nutrition education program called "Color My Pyramid" to teach students how to evaluate their dietary intake and activity level. The program incorporates the Department of Agriculture's MyPyramid.
    10/08/2008 02:00 AM
  • New Target For Obesity-Related Insulin Resistance, Type 2 Diabetes
  • Building on mounting evidence that implicates infection-fighting cells found in obese fat tissue in the growing problem of insulin resistance and Type 2 diabetes, researchers at the University of California, San Diego, School of Medicine have identified a particular subset of cells that are linked to obesity-associated insulin resistance, and that offer a promising new target for the treatment of diabetes.
    10/07/2008 08:00 AM
  • VIVUS Announces The Weight Loss Effects Of Qnexa In Type 2 Diabetes - Shows Weight Loss Of 17 Pounds In 28 Weeks
  • VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced the weight loss effects of Qnexa in subjects with type 2 diabetes at The Obesity Society Annual Scientific Meeting in Phoenix, Arizona. Dr. Barbara Troupin, Senior Director of Clinical Development, announced the data in a poster presentation titled "The Weight Loss Effects of VI-0521 in Type 2 Diabetes.
    10/07/2008 07:00 AM
  • Patent Awarded To LSUHSC For Compound Inhibiting Cancer And Other Diseases
  • Dr. Eugene Woltering, the James D. Rives Professor of Surgery and Neurosciences at LSU Health Sciences Center New Orleans School of Medicine, and Dr. Conrad Hornick, former LSUHSC Professor of Physiology, have been awarded a US Patent for a compound to inhibit the formation of blood vessels critical to the growth of cancerous tumors and diseases like diabetic retinopathy, obesity, and psoriasis.
    10/07/2008 06:00 AM
  • Parents Foster Significant Misperceptions Of Children's Weight
  • Results of a survey presented at the American College of Gastroenterology's 73rd Annual Scientific Meeting in Orlando revealed that many parents do not accurately perceive their children as overweight or at risk for adulthood obesity. Obesity in the United States is often accompanied by an increased risk of gastrointestinal diseases and has emerged as a major health concern, particularly the issue of obesity among children and adolescents. Researcher Rona L. Levy, Ph.D.
    10/07/2008 04:00 AM
  • Cost Of Obesity To Local Health Services Revealed, UK
  • PCTs count the cost of bad diet and exercise New figures out today show, for the first time, the cost of obesity to every Primary Care Trust in England. The figures set out the cost of diseases related to being overweight or obese in 2007 and how much it will cost at a local level in 2015 if we take no action. As last years Foresight report highlighted, nationally the cost of being overweight or obese cost the NHS £4.2 billion in 2007.
    10/07/2008 04:00 AM
  • Empatic™ Shows Long-Term Weight Loss, Improved Quality Of Life Contrave(R) Reduces Rate Of Metabolic Syndrome By Half
  • Orexigen Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity and other central nervous system-related disorders, today announced that the company reviewed in an oral presentation at the Obesity Society Annual Scientific Meeting that the investigational drug, Empatic™ (zonisamide SR/bupropion SR), demonstrated up to 15% reduction in body weight of healthy obese people who completed 48-weeks of treatment in the absence of diet and exercise.
    10/07/2008 03:00 AM
  • Obese Women's Efforts To Get Exercise Hampered By Mental Barriers
  • For arachnophobes, it's difficult to kill a spider as it scurries across the floor. Those who are scared to fly might not ever set foot on a plane. While nothing physically stops people with these aversions, a mental barrier can keep them from the task at hand. The same could be said for obese women when it comes to physical activity, according to research presented at the Obesity Society's Annual Meeting.
    10/07/2008 02:00 AM
  • Orexigen(R) Therapeutics Presents Data On Its Proprietary Formulation Of Naltrexone Sustained Release (SR) Used In Contrave(R)
  • Orexigen Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity and other central nervous system-related disorders, presented data showing the investigational drug, Contrave(R) (naltrexone SR / bupropion SR), successfully achieved key objectives (lowered naltrexone Cmax, increased Tmax, comparable AUC) in two Phase 1 clinical trials.
    10/07/2008 02:00 AM
  • Genaera Corporation Reports Phase 1 Data For Trodusquemine (MSI-1436) At The North American Association For The Study Of Obesity Annual Meeting
  • Genaera Corporation (Nasdaq: GENR) reported data from its second Phase 1 clinical trial of trodusquemine (MSI-1436), Genaera's lead drug candidate for the treatment of type 2 diabetes and obesity. MSI-1436 is a novel inhibitor of PTP1B, a validated molecular target that controls the function of both the leptin and insulin pathways to normalize glucose and decrease appetite.
    10/06/2008 12:00 PM
  • Concord Grape Juice Has No Significant Impact On Body Weight
  • Regular consumption of 100% polyphenol-rich Concord grape juice did not cause significant weight gain, was not associated with changes in appetite and was shown to reduce waist circumference according to new data presented at the 49th Annual Meeting of the American College of Nutrition in Arlington, Virginia.
    10/06/2008 11:00 AM
  • Obese Diners Choose Convenience And Overeating At Chinese Buffets
  • When dining at Chinese Buffets, overweight individuals serve themselves and eat differently than normal weight individuals. This may lead them to overeat, according to a recent study by Cornell University's Food and Brand Lab. Compared to normal weight diners, overweight individuals sat 16 feet closer to the buffet, faced the food, used larger plates, ate with forks instead of chopsticks, and served themselves immediately instead of browsing the buffet.
    10/06/2008 10:00 AM
  • School Vending Machines Dole Out Excess Calories, Fat - USA
  • Despite efforts to include more healthy choices at schools, standard offerings from vending machines - including fruit juices - are giving students more calories than they need. Recent figures from the HEALTHY Study, a nationwide effort led by Temple University to curb obesity and type 2 diabetes in middle school students, found vending machines beverages had added sugars, high calorie 100 percent fruit juices, and snacks over 200 hundred calories.
    10/06/2008 08:00 AM
  • Severely Obese Benefit Greatly From A Little Bit Of Exercise
  • A little exercise goes a long way toward helping severely obese individuals improve their quality of life and complete important daily tasks, according to researchers at the Duke Diet and Fitness Center. In a pre-program assessment where patients reported, on average, just under one hour of exercise per week, individuals who were more active reported better overall-quality of life.
    10/06/2008 03:00 AM
  • Merck Discontinues Development Of Investigational Medicine Taranabant For Obesity
  • Merck & Co., Inc. will not seek regulatory approval for taranabant, an investigational medicine, to treat obesity and is discontinuing its Phase III clinical development program for taranabant for obesity. "Available Phase III data showed that both efficacy and adverse events were dose related, with greater efficacy and more adverse events in the higher doses.

    See also: Exercise and fitness news

    Health Related Ads

    Additional Health Resources